Skip to content

Author

Jennifer A. Rymer

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

One-year mortality, cardiovascular and limb events in the BEST-CLI Registry of chronic limb threatening ischemia patients.

BACKGROUND Patients with chronic limb threatening ischemia (CLTI) are at risk for cardiovascular events, amputations, hospitalizations, and death. We aimed to describe 1-year outcomes of a broader, non-clinical trial cohort of CLTI patients at a subset of BEST-CLI trial sites. METHODS The BEST-CLI Registry enrolled p...

E. Weissler, Shuang Li, Nishant P. Shah et al. · 0 citations
Review Aug 2026

Antithrombotic therapy to minimize total events after ACS or PCI in atrial fibrillation: insights from AUGUSTUS.

For patients with AF after ACS or PCI, DOAC-based dual antithrombotic therapy provides the most favorable cumulative safety-efficacy balance, and future research should focus on the timing of aspirin discontinuation and validate recurrent-event endpoints.

Seung-Hun Lee, Jennifer A. Rymer, W. S. Jones · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.